Finally, to assess whether SV2A and other synaptic markers are reduced in BDEVs and whether SV2A levels are correlated with other recently proposed CSF panel biomarkers of synaptic dysfunction in neurodegenerative diseases [53], we performed nonparametric Spearman’s rank correlation analyses. The gene discussed is SV2A; the disease is neurodegenerative disease.